BioNano Genomics Inc
General ticker "BNGO" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $20.0M
BioNano Genomics Inc does not follow the US Stock Market performance with the rate: -30.9%.
Estimated limits based on current volatility of 3.8%: low 0.20$, high 0.21$
Factors to consider:
- North and South America accounted for 49.9% of revenue in the fiscal year ended 2023-12-31
- Current price 84.2% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.23$, 4.12$]
- 2024-12-30 to 2025-12-30 estimated range: [1.34$, 3.94$]
Financial Metrics affecting the BNGO estimates:
- Negative: Non-GAAP EPS, $ of -4.88 <= 0.10
- Negative: Operating profit margin, % of -85.63 <= 1.03
- Negative: Operating cash flow per share per price, % of -69.68 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
Short-term BNGO quotes
Long-term BNGO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $17.98MM | $27.80MM | $36.12MM |
| Operating Expenses | $95.08MM | $159.50MM | $251.36MM |
| Operating Income | $-77.10MM | $-131.70MM | $-215.25MM |
| Non-Operating Income | $-1.05MM | $0.99MM | $-17.19MM |
| Interest Expense | $0.93MM | $0.30MM | $5.12MM |
| R&D Expense | $22.48MM | $49.05MM | $54.03MM |
| Income(Loss) | $-78.15MM | $-130.71MM | $-232.43MM |
| Taxes | $-5.72MM | $1.88MM | $0.06MM |
| Profit(Loss) | $-72.44MM | $-132.60MM | $-232.49MM |
| Stockholders Equity | $337.12MM | $249.40MM | $96.16MM |
| Inventory | $12.39MM | $29.76MM | $22.89MM |
| Assets | $377.10MM | $307.50MM | $214.40MM |
| Operating Cash Flow | $-71.93MM | $-124.82MM | $-125.18MM |
| Capital expenditure | $1.46MM | $3.30MM | $1.69MM |
| Investing Cash Flow | $-278.06MM | $82.77MM | $24.16MM |
| Financing Cash Flow | $336.11MM | $23.01MM | $113.81MM |
| Earnings Per Share* | $-2.62 | $-4.58 | $-6.81 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.